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ABSTRACT  
Endogenous retroviruses (ERVs) undergo de novo DNA methylation during the first few 
days of mammalian embryogenesis, although the factors that control the targeting of this 
process are largely unknown. We asked if KAP1 (KRAB-associated protein 1) is 
involved in this mechanism because of its previously defined role in maintaining ERVs 
silent through the histone methyltransferase ESET and histone H3 lysine 9 trimethylation. 
Here, we demonstrate that introduced ERV sequences are sufficient to direct rapid de 
novo methylation of a flanked promoter in embryonic stem (ES) cells. This mechanism 
requires the presence of an ERV sequence-recognizing KRAB-zinc finger protein (ZFP) 
and both KAP1 and ESET. Furthermore, this process can also take place on a strong 
cellular promoter and leads to methylation signatures that are subsequently maintained in 
vivo throughout embryogenesis. Finally, we show that methylation of ERVs residing in 
the genome is affected by knockout of KAP1 in early embryos. KRAB-ZFPs, KAP1 and 
ESET are thus likely responsible for the early embryonic instatement of stable epigenetic 
marks at ERV-containing loci. 
 
Keywords: de novo DNA methylation / endogenous retroviral silencing / KRAB-
associated protein 1 (KAP1) / TRIM28 / TIF1β / KRAB-zinc finger protein (KRAB-ZFP) 
/ ESET / SETDB1 
 3
INTRODUCTION 
 
Endogenous retroviruses (ERVs) account for close to ten percent of mammalian genomes 
(Waterston et al., 2002) and are both drivers of evolution and threats to genetic integrity, 
because of their ability first to retrotranspose and second to alter the expression of 
neighboring genes through cis-acting transcriptional influences. In mice, ERVs display 
residual retrotransposition activity, leading to polymorphic integrations and differential 
gene regulation between mouse strains (Qin et al., 2010; Takabatake et al., 2008; Zhang 
et al., 2008). Moreover, around ten percent of spontaneous mutations in inbred mice are 
linked to ERVs (Maksakova et al., 2006), for instance dactylaplasia that results from a 
MusD neo-insertion (Friedli et al., 2008; Kano et al., 2007). In humans, the non-LTR 
retroelement LINE1 (L1) retains some activity and, remarkably, patients with Rett 
syndrome due to mutations in the DNA methylation binding protein MeCP2 are more 
prone to L1 retrotransposition (Muotri et al., 2010).  
ERVs are duly inactivated during early embryogenesis by histone modifications and de 
novo DNA methylation (reviewed in (Rowe and Trono, 2011)). This process counteracts 
the prior genome-wide erasure of DNA methylation that begins at the zygote phase, 
leaving transposons in a lowly methylated state including L1s and to a lesser extent 
intracisternal A-type particles (IAPs), (Feng et al., 2010; Lane et al., 2003). De novo 
DNA methylation is key to ERV repression from plants to mammals, and involves 
methylation of cytosine residues at CpG dinucleotides by the enzymes DNMT3A and 
DNMT3B, acting in conjunction with their catalytically inactive cofactor DNMT3L 
(Chedin et al., 2002; Okano et al., 1999; Suetake et al., 2004). Later in development and 
in adult tissues, levels of de novo methyltransferases are reduced compared to 
preimplantation embryos (Carlson et al., 1992), yet pre-established DNA methylation 
patterns are perpetuated during DNA replication by the maintainance DNA 
methyltransferase DNMT1, recruited to hemimethylated DNA by UHRF1 (Bestor et al., 
1988; Bostick et al., 2007; Sharif et al., 2007). DNA methylation is particularly crucial to 
constrain the transcription of some ERVs including IAPs, the expression of which 
become uncontrolled following inactivation of DNA methylation machinery (Bourc'his 
and Bestor, 2004; Chen et al., 2003; Gaudet et al., 2004; Walsh et al., 1998), although not 
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in DNMT1 knockout ES cells unless they are first differentiated (Hutnick et al., 2010), 
highlighting the particular importance for DNA methylation later in development. 
Interestingly, alterations in ERV DNA methylation patterns impact on the expression of 
neighbouring genes (Duhl et al., 1994; Macfarlan et al., 2011; Macfarlan et al., 2012; 
Michaud et al., 1994; Rebollo et al., 2011).  
DNA methylation is conditioned by the density and spacing of CpG dinucleotides, can be 
affected by DNA-binding proteins such as CTCF and REST, and is influenced by the 
histone code, with for instance methylation of histone 3 at lysine 4 (H3K4) preventing the 
docking of the DNMT3A-DNMT3L complex (Glass et al., 2009; Jia et al., 2007; Lienert 
et al., 2011; Okitsu and Hsieh, 2007; Ooi et al., 2007; Stadler et al., 2011; Weber et al., 
2007). The factors and pathways that recruit de novo DNA methylases to specific 
genomic targets, notably ERVs, remain largely undefined, although it was recently shown 
that DNMT3L and the lysine methyltransferase G9a are factors required for the initiation 
of proviral de novo DNA methylation (Leung et al., 2011; Ooi et al., 2010). 
Here, we investigate the role played in this process by KAP1 (KRAB-associated protein 1, 
also known as tripartite motif protein 28 –TRIM28- or TIF1b), a cofactor to the 
sequence-specific DNA-binding KRAB-zinc finger proteins (ZFPs), a large family of 
tetrapod-restricted transcriptional factors that co-evolved with ERVs (Emerson and 
Thomas, 2009; Friedman et al., 1996; Thomas and Schneider, 2011; Urrutia, 2003). 
KAP1 was previously demonstrated to maintain ERVs in a silent state in embryonic stem 
(ES) cells via the histone methyltransferase ESET (also known as SETDB1) and 
secondary H3K9 trimethylation (Matsui et al., 2010; Rowe et al., 2010). It is also known 
that the artificial tethering of a KRAB domain to the vicinity of a promoter can lead to its 
DNA methylation in transgenic mice but not in ES cells (Wiznerowicz et al., 2007), and 
that maintenance of imprinting marks depends on ZFP57 and KAP1 (Li et al., 2008; 
Messerschmidt et al., 2012; Quenneville et al., 2011; Zuo et al., 2012). Of relevance here, 
the retrovirus murine leukemia virus (MLV) is known to be recognized by the mouse-
specific KRAB-ZFP ZFP809 through its proline primer binding site (PBS Pro) sequence 
and undergos KAP1-dependent silencing in embryonic carcinoma (EC) cells (Wolf et al., 
2008; Wolf and Goff, 2007; Wolf and Goff, 2009), although it is not known if these 
factors are sufficient to promote DNA methylation. Of note, MLV-based vectors are 
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themselves prone to DNA methylation weeks after their integration in ES or EC cells, 
through a process that is independent of the presence of a PBS Pro sequence (Leung et al., 
2011; Niwa et al., 1983; Wang et al., 1998), as also documented for the cytomegalovirus 
(CMV) promoter (Meilinger et al., 2009). 
Determining how particular ERVs are targeted for de novo DNA methylation is 
technically challenging, owing to their genomic representation in multiple copies of often 
differentially methylated status in ES cells and early embryos. To circumvent this 
difficulty, we inserted previously identified genomic targets of KAP1 derived either from 
the proximal region of IAPs or from PBS Pro (present in some 146 endogenous MLVs in 
the C57Black6 mouse genome) into lentiviral vectors, either upstream or downstream of 
a promoter driving a GFP reporter. In both configurations, these introduced retroviral 
elements were sufficient to induce not only the silencing but, in parallel, de novo DNA 
methylation of the flanking promoter. Methylation was remarkably rapid with an adjacent 
retroviral promoter (MND), occuring within 48 hours, but slower with a cellular promoter 
(PGK), occuring within six days. For PBS Pro, we could demonstrate that DNA 
methylation was conditioned by the expression of ZFP809. We then determined that de 
novo DNA methylation of introduced ERVs in ES cells was dependent on both KAP1 
and ESET, and that sequence-specific ERV methylation could be recapitulated in vivo 
and maintained through development, with ERV sequences directing DNA methylation 
of an adjacent retroviral or cellular promoter. Finally, we documented that methylation 
footprints of genomic ERVs are affected by KAP1 loss in early embryos. These data 
reveal that KAP1 shapes DNA methylation signatures at ERV-containing loci in early 
mouse development. 
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MATERIALS AND METHODS 
 
Lentiviral vectors 
All MND vectors are described before (Rowe et al., 2010). For ERV-directed repression 
of a cellular promoter, the transfer vector pRRLSIN.cPPT.PGK-GFP.WPRE (available 
from Addgene) was employed that contains a human phosphoglycerate kinase-1 (PGK) 
promoter to distinguish it from the endogenous mouse promoter during methylation 
analysis. Pro and B2 sequences were cloned into this vector by annealing primers 
upstream (into the XhoI site) or downstream (between the BamHI and AgeI sites) of the 
promoter in the antisense orientation. Or IAP1 or IAP4 (described before, (Rowe et al., 
2010)) were cloned upstream of the promoter into the XhoI site in the antisense 
orientation. Cloning was verified by sequencing (Microsynth). Vectors were produced by 
transient transfection of 293T cells with the transfer vector, packaging and VSVG 
envelope plasmids (Barde et al., 2010) and titrated on 3T3 fibroblasts. 
 
Cell culture and flow cytometry 
ES cells were cultured in Glasgow Minimum Essential Media (GMEM, Sigma: G5154) 
with sodium pyruvate (used at 1mM, Sigma: S8636), MEM non-essential amino acids 
(used at 1x, Gibco: 11140-035), L-glutamine (used at 2mM, Gibco: 25030-024), 2-
mercaptoethanol (used at 0.1mM, Sigma), ES cell tested FBS (Gibco: 16141-079) and 
leukaemia inhibitory factor (LIF, used at 1,000 units/ml, Chemicon: ESG1107). Cells 
were grown on 0.2% gelatin (Sigma: 48723-500G-F)-coated plates and split every two 
days. ES cell lines used were two KAP1loxP/loxP lines called ES3 and ES6 and their 
derived KAP1-conditional knockout cell lines that are transduced with tamoxifen (4-
0HT)-inducible cre (Rowe et al., 2010). Knockout cells were collected 3-4 days after 
treatment with 4-0HT (overnight at 1mM, Sigma: H7904) as stated. G9a parental or 
stable knockout ES cells and Eset-inducible knockout ES cells were from Yoichi Shinkai  
(Dong et al., 2008; Matsui et al., 2010; Tachibana et al., 2008) (The RIKEN Institute, 
Japan). DNMT1-/-, DNMT3A-/-, DNMT3B-/- (triple knockout or TKO) ES cells were 
from Masaki Okano (Tsumura et al., 2006) (The RIKEN Institute, Japan). F9 EC 
(embryonic carcinoma) cells, primary mouse embryonic fibroblasts (MEFs), 3T3 
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fibroblasts and 293T cells were also used where stated. Vector titers and GFP repression 
were measured by flow cytometry and for KAP1 and ESET knockout experiments, cells 
were stained with an anti-SSEA-1 PE- conjugated antibody or isotype control (BD 
Pharmingen: 560142 and 555584) and SSEA-1 high-expressing cells gated for 
undifferentiated cells. 
 
Quantitative bisulfite pyrosequencing 
Genomic DNA was converted (200ng/sample) using an EpiTect Bisulfite kit (Qiagen: 
59104) and used for PCR (primers, one tagged with biotin, were designed using 
PyroMark Assay Design Software 2.0). PCR products were checked by Sanger 
sequencing and verified on agarose gels for each experiment before immobilizing on 96 
well plates using a Vacuum Prep Workstation and pyrosequencing using PyroMark Gold 
Reagents (Qiagen: 972804). We thank Alex Reymond and Jacqueline Chrast for kind use 
of their pyrosequencer (at the Center for Integrative Genomics, University of Lausanne, 
Switzerland). Results were analysed using Pyro Q-CpG Software. See Supplementary 
Table I for primer sequences. 
 
Immunoblotting 
Cells were washed with cold PBS and resuspended in radioimmunoprecipitation buffer to 
prepare total cell extracts. Protein was quantified by BCA Protein Assay Reagents 
(Pierce) and normalized for loading on a 10% denaturing SDS-polyacrylamide gel. Wet 
transfer was performed and primary antibodies used were: anti-KAP1 (Mouse mAb, 
MAB3662, Chemicon), anti-IAP GAG (kind gift from Bryan Cullen, Duke University, 
U.S.A., see (Bogerd et al., 2006)) and anti-PCNA (mouse mAb, clone PC10, Cat. No. 
NA03, Calbiochem). 
 
293T cell transfection 
Cells were seeded at 1x10e5 per well in a 12 well plate and transfected with 100ul 
transfection mix per well, containing 6ul FuGene 6 (Promega) and 1ug DNA in serum 
free media, after incubating this mixture for 15 minutes at room temperature. 
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Quantification of RNA and DNA copy number 
RNA was extracted and qRT-PCR performed as before (Rowe et al., 2010). Primer 
specificity was confirmed by dissociation curves and samples normalized to Titin, Gapdh, 
or Eef1a1 in Fig. 2D because it reacts with both human and mouse Eef1a1. For in vivo 
experiments, genomic DNA was extracted from embryos to measure DNA copy numbers 
by performing Taqman qPCR for HIV Gag, GFP and Titin as a normalizer, in 
comparison to a titration curve of plasmid containing sequences of HIV Gag, GFP and 
Titin. A cell line with a known number of vector copies was used as control. Results 
presented are means of values obtained for HIV Gag and GFP primers. See 
Supplementary Table I for primer sequences. 
 
Lentiviral transgenesis 
Lentiviral vectors for transgenesis were prepared using Episerf medium (Invitrogen: 
10732022), the particle concentration obtained by p24 ELISA (Perkin-Elmer: 
NEK050B001KT) and the infectious titer determined on HCT116 cells by GFP flow 
cytometry. Vectors for each transgenesis experiment were produced and titered in parallel 
in order to be in the same range. Fig. 4 titers: 2x10e9 (IAP2 MND) and 4x10e9 (MND). 
Fig. 5 titers: 1.4x10e9 (PGK Pro) and 1.2x10e9 (PGK). Fig. S4B titers: 2.3x10e9 (IAP4 
PGK) and 2.4x10e9 (IAP1 PGK). Transgenesis was performed by perivitelline injection 
of vectors into fertilized oocytes that were transferred to foster mothers (strain B6D2F1/J) 
and then recovered at E13. Photographs were taken using the same saturation, gain and 
exposure settings for all embryos, and GFP results displayed all represent the same image 
processing settings.  
 
Statistics 
GraphPad Prism version 4.00 (www.graphpad.com) was used for all statistical analyses. 
For all DNA methylation analyses, two groups (as detailed in the legends) were 
compared across multiple CpG positions using paired two-tailed t tests (except where 
stated). Any additional statistical analyses are specified in the legends. 
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RESULTS 
 
Introduced ERV sequences can induce rapid de novo DNA methylation in ES cells 
Since repeat-derived sequences are largely methylated in ES cells, we set up a method to 
measure the de novo DNA methylation directed at ERV-specific elements by cloning 
these into lentiviral vectors, a gene transfer system itself not prone to spontaneous 
methylation, compared to MLV-based vectors (Wang et al., 1998). To quantify levels of 
de novo DNA methylation, we used bisulfite pyrosequencing and verified this technique 
with primers for endogenous ERVs and the Oct4 promoter confirming the latter to be 
methylated in mouse embryonic fibroblasts (MEFs) but not ES cells, whereas the bulk  of 
ERVs harbored this modification in both cell types (Fig. 1A). In ES cells transduced with 
lentiviral vectors, we confirmed that PBS Pro and previously described KAP1-sensitive 
IAP elements mediated repression of an adjacent MND retroviral promoter, whether 
placed upstream or downstream (Fig. 1B and Fig. S1A) as previously reported (Rowe et 
al., 2010). Bisulfite analyses then further revealed that de novo DNA methylation 
systematically correlated with repression, and that it surprisingly was present at four days 
post-transduction (Fig. 1C). A time-course study showed that this process was already 
under way at day 3 and then progressively increased, with mean levels across the 
promoter reaching around 75% at day 7 (Fig. S1B). Control vectors, whether containing 
no KAP1-targeted retroviral sequence, the point-mutated B2 PBS Pro derivative, or the 
previously identified KAP1-insensitive IAP1 element (Rowe et al., 2010), underwent 
neither repression nor DNA methylation. Moreover, in 3T3 fibroblasts, no ERV-directed 
promoter methylation was detected, suggesting this process may be restricted to ES cells 
(Fig. 1C).  
 
ERV DNA methylation patterns are conditioned by KRAB-ZFP expression profiles 
KAP1 has previously been shown to repress ERVs in ES cells and early embryos (Rowe 
et al., 2010) and is known to be recruited to specific DNA sequences through KRAB-
ZFPs (Friedman et al., 1996; Thomas and Schneider, 2011). One characterized KRAB-
ZFP is ZFP809, which targets KAP1 to the PBS Pro sequence (Wolf and Goff, 2007; 
Wolf and Goff, 2009). Since we previously found ERVs to be regulated by KAP1 in 
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mouse ES cells but not in MEFs (Rowe et al., 2010), we hypothesized that this difference 
may correlate with the expression profiles of KRAB-ZFPs, especially since KAP1 is 
itself still present in MEFs. We therefore used mRNA-sequencing data from ES cells and 
MEFs to compare expression levels of KRAB-ZFPs between these cell types. While most 
KRAB-ZFPs were enriched in ES cells compared to MEFs (although there is no evidence 
that any of them repress ERVs), with mean expression levels at 3.421 and 1.4242 
respectively, ZFP809 displayed similar levels in the two cell types (Fig. 2A and data not 
shown). Correspondingly, when we compared silencing of the PBS Pro and IAP vectors 
in MEFs, we found the former but not the latter to undergo repression in these cells (Fig. 
2B), consistent with the lack of activation of endogenous IAPs in MEFs upon KAP1 
removal (Rowe et al., 2010). Indeed, we propose that IAPs are already stably methylated 
in MEFs so it is not necessary for their cognate KRAB-ZFP to be maintained. PBS Pro-
induced repression was accompanied by de novo DNA methylation in MEFs, albeit at 
lower levels than in ES cells (Fig. 2C). In order to demonstrate this mechanism to be 
determined by the presence of the KRAB-ZFP, we complemented human 293T cells with 
mouse ZFP809, leading to repression but also significant PBS Pro-dependent DNA 
methylation of the adjacent promoter (Fig. 2D-F). This level of DNA methylation, 
however, is not sufficient to maintain silencing, which is reversible (Fig. S2). 
 
KAP1 and ESET are required for de novo DNA methylation of ERVs 
In order to determine the role of KAP1 in ERV de novo DNA methylation, we used a 
previously described conditional knockout ES cell line (Rowe et al., 2010). Since Kap1 
deletion is ultimately lethal in early embryos and ES cells ((Rowe et al., 2010) and see 
Fig. S3), experiments were performed within three days of inducing this process (a time-
point established from Fig. S1B). At that point, both repression and DNA methylation of 
the lentivirally introduced, IAP- or Pro PBS-flanked promoter could be documented in 
control cells, while both processes were abrogated by KAP1 removal (Fig. 3A-C). 
Similar experiments in Eset-conditional knockout ES cells demonstrated this histone 
methyltransferase to also be required for ERV-directed repression and de novo DNA 
methylation (Fig. 3D-F). Both KAP1 and ESET are thus necessary not only for the 
maintenance of proviral silencing (Leung et al., 2011; Matsui et al., 2010; Rowe et al., 
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2010), but also required initially for de novo DNA methylation of introduced ERV 
sequences. 
 
ERV-guided KAP1-induced DNA methylation is recapitulated in embryogenesis 
De novo DNA methylation patterns established early in embryogenesis are maintained 
later in development through the action of DNMT1 (Gaudet et al., 2004; Walsh et al., 
1998). We asked if DNA methylation marks promoted by KAP1 in ES cells could also be 
induced in vivo, and whether in this setting they were perpetuated until late in 
embryogenesis. To this end, control and KAP1-sensitive IAP sequence-containing MND-
GFP lentiviral vectors were injected into fertilized mouse oocytes, and the resulting 
embryos were collected at E13 to assess integration, repression and promoter methylation. 
While all embryos containing the control vector were bright or dull green, none of the 
IAP LV-harbouring embryos expressed GFP to detectable levels, whether examined by 
microscopy or by flow cytometry (Fig. 4A,B). Of note, MEFs transgenic for the non-
repressed promoter displayed variability in GFP intensity within the population likely due 
to KAP1-independent silencing mechanisms, including relating to integration site 
differences (Barklis et al., 1986; Ellis, 2005). Strikingly, DNA methylation at E13 
mirrored data obtained in ES cells, with high promoter methylation for all IAP-vector-
harboring embryos, whereas DNA methylation of the lentivirally introduced promoter 
was lower and more variable in the absence of an adjacent KAP1-tethering element (Fig. 
4C). These results suggest that KAP1 machinery acts in early embryos as a lock to ensure 
active DNA methylation and thus robust ERV silencing throughout development.  
 
ERV sequences can induce repression and DNA methylation of a cellular promoter 
Since cellular promoters can lie in close proximity to ERVs in the genome and ERV 
methylation status can influence cellular gene expression (Duhl et al., 1994; Macfarlan et 
al., 2011; Macfarlan et al., 2012; Michaud et al., 1994; Rebollo et al., 2011), we assessed 
whether our KAP1-dependent ERV sequences could also direct de novo DNA 
methylation of a cellular promoter. PBS Pro could induce some repression of a 
juxtaposed PGK (phosphogylcerate) promoter, albeit less efficiently than for MND, and 
with only minimal if any DNA methylation at day 3 post-transduction (Fig. 5A). 
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However, by six days, repression was clear (around 7-fold, Fig. S4A) so we used this 
time-point to demonstrate that both PBS Pro and IAP sequences could direct de novo 
DNA methylation of the cellular promoter with levels further increasing after twelve days 
(Fig. 5B). Furthermore, PBS Pro or a KAP1-sensitive IAP sequence induced repression 
and DNA methylation of the adjacent PGK promoter when lentiviral vectors containing 
these elements were used to generate transgenic embryos (Fig. 5C and Fig. S4B).  
 
KAP1 shapes DNA methylation of endogenous retroviruses in ES cells and embryos 
Our Southern blot analyses previously failed to detect significant global loss of DNA 
methylation at ERVs upon Kap1 deletion (Rowe et al., 2010) but here, we revisited this 
issue using the more sensitive bisulfite pyrosequencing technique to examine ERVs in ES 
cells and early embryos. As expected, IAPs became highly overexpressed following 
KAP1 removal in ES cells, which here we record to translate in a marked accumulation 
of IAP GAG protein (Fig. 6A). We then measured IAP methylation, using the Oct4 
promoter as a control (Fig. 6B): Whereas global IAP LTRs were unaffected in Kap1-
knockout MEFs, they displayed a mild but significant decrease in knockout ES cells in 
line with the minimal decrease previously observed at ERVs in Eset-knockout ES cells 
(Matsui et al., 2010). A comparatively greater loss of IAP DNA methylation was 
measured in an ES cell line stably deleted for the the G9a histone methyltransferase 
(Dong et al., 2008; Tachibana et al., 2008). However, this cell line grows continuously, 
allowing cumulative decreases in DNA methylation, whereas Kap1-deleted cells only 
divide a few times before dying. The overexpression of IAPs in Kap1-deleted cells is 
most likely a consequence of the removal of histone repressive marks such as H3K9me3 
(Matsui et al., 2010; Rowe et al., 2010), especially as we confirmed with conventional 
bisulphite sequencing at one IAP locus that no molecules are completely or even largely 
demethylated (Fig. S5). However, it is possible that such a small decrease in DNA 
methylation contributes to the phenotype, particularly as we find that 5-Aza treatment of 
MEFs induces fairly conservative decreases in IAP DNA methylation (Fig. S6), yet a 
massive upregulation of their transcription (Fig. 7B). Interestingly, we also found using 
two different primer sets, that DNA methylation levels at ERVs were mildly but 
significantly lower in E5.5 Kap1 knockout embryos compared to wild type littermates 
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(Fig. 6C and Fig. S7). Although only 1/23 further knockout embryos was obtained (at 
E4.5), likely due to the high lethality, this embryo also displayed less DNA methylation 
at IAPs than its two control littermates (p=0.0002 and 0.0014 respectively, data not 
shown). Altogether, these data support a role for KAP1 in genome-wide ERV DNA 
methylation during early embryogenesis. 
 
DNA methylation becomes critical for ERV silencing later in development 
Finally, in order to address the relevance of DNA methylation of ERV sequences and 
endogenous ERVs in development, we derived MEFs from transgenic embryos in which 
our ERV-derived proviruses were integrated. Treatment with the DNA methyltransferase 
inhibitor 5-aza (but not the HDAC inhibitor, TSA) was sufficient to relieve silencing and 
this was true for both ERV sequences newly introduced within the context of lentiviral 
vectors and endogenous IAPs that were upregulated by up to around 700 fold (Fig. 7). To 
ask if DNA methylation already played a role in silencing ERVs at an earlier 
developmental stage, we also examined DNMT triple knockout (TKO) ES cells (Tsumura 
et al., 2006), in which all three DNA methyltransferases are deleted (Fig. S8). Levels of 
IAP GAG protein and of IAP and MERV-L RNA were significantly higher in these than 
in control ES (Fig. S8A,B), consistent with a previous study (Matsui et al., 2010). Of 
note, it was recently reported that in DNMT1 KO ES cells and in another ES cell line 
where all DNMT proteins were depleted (by knockout of DNMT3A/3B and knockdown 
of DNMT1) (Meissner et al., 2005), IAP protein was only detected upon LIF (leukemia 
inhibitory factor) withdrawal, hence induction of differentiation for six or more days, a 
time point at which OCT4 protein was undetected in differentiated cultures by 
immunofluoresence (Hutnick et al., 2010). However, the TKO ES cells used here were 
maintained in standard ES cell conditions (see methods) and were largely 
undifferentiated as indicated by comparable levels of OCT4 protein to WT (Fig. S8A) as 
well as high surface expression of SSEA1 (Fig. S8C), in contrast to ES cells cultured 
without LIF, which downregulated this marker (Fig. S8D). In addition, these cells have 
previously been found to conserve their self-renewal ability (Tsumura et al., 2006). Still, 
we cannot exclude that some differentiating cells contributed more prominently to the 
observed IAP upregulation. Importantly, the overexpression of these elements in ES cells 
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(around 40 fold) is modest compared to that seen in MEFs (Fig. 7) supporting a critical 
role of DNA methylation in ERV silencing later in development (Gaudet et al., 2004; 
Walsh et al., 1998) in contrast to in ES cells where KAP1-dependent histone methylation 
is present (Hutnick et al., 2010; Karimi et al., 2011; Matsui et al., 2010; Rowe et al., 
2010) and reviewed in (Leung and Lorincz, 2011; Rowe and Trono, 2011). Indeed both 
5-aza treatment and KAP1 knockout need to be performed to induce such a dramatic 
upregulation of IAPs in ES cells (to around 400 fold, (Rowe et al., 2010)).  
 
DISCUSSION 
The present work demonstrates the involvement of sequence-specific KRAB-ZFPs, 
KAP1, and ESET in establishing early embryonic DNA methylation patterns at ERV 
sequences that are subsequently maintained through embryogenesis. This suggests these 
factors to be required during early development first for the histone-based silencing and 
then for the de novo methylation of genomic ERVs, even though the evidence provided 
here is limited to newly introduced ERV sequences. Our results support a model (Fig. 
6D) whereby sequences located in the 5’ region of ERV genomes recruit specific KRAB-
ZFPs, which brings about KAP1, ESET and most likely other chromatin modifiers, the 
conjugated action of which leads to transcriptional repression and de novo promoter 
methylation. This phenomenon implies the secondary recruitment of de novo DNA 
methyltransferases, consistent with the documented immunoprecipitation of KAP1 with 
DNMT3A and DNMT3B (Li et al., 2008; Quenneville et al., 2011; Zuo et al., 2012), and 
the reported interaction of DNMT3A with the B-Box coiled coil domain of KAP1 (Zuo et 
al., 2012). Since ERV DNA methylation requires ESET, it could be that this enzyme 
directly recruits DNMT3AB and 3L. In that respect, histone methyltransferases have 
previously been revealed to act as docking sites for DNA methylation machinery (Dong 
et al., 2008; Tachibana et al., 2008) and, importantly, ESET has been proposed to bind 
directly to DNMT3A and tether it to promoters, leading to their DNA methylation-
mediated silencing (Li et al., 2006). Alternatively, de novo DNA methylation may result 
indirectly from a lack of transcription and in turn active marks such as H3K4me3 (Jia et 
al., 2007; Ooi et al., 2007), due to the recruitment of H3K9me3 and histone deacetylation 
at ERVs. 
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We reveal here that KAP1-recruiting ERV sequences are able to trigger repression and de 
novo DNA methylation of a strong cellular promoter as well as of a retroviral promoter, 
at least within the context of newly introduced lentiviral vectors. The slower kinetics 
observed with the PGK promoter, compared with its MND counterpart, may be due to 
partial protection of its CpG-dense core by transcription factors, as recently proposed 
(Lienert et al., 2011; Stadler et al., 2011). These data indicate that KAP1-mediated 
silencing of ERVs may dampen expression from nearby cellular transcription units by 
inducing promoter CpG methylation. This is supported by our observation that the 
methylation status of CpG islands correlating with their immediate proximity to KAP1-
recruiting sites in ES cells (Quenneville et al., 2012). Relevant to ERVs, in a recent study, 
polymorphic copies of ERVs across mouse strains were employed to determine whether 
histone and DNA methylation marks could spread from ERVs to cellular promoters. 
Results showed that, while H3K9me3 marks could spread several kilobases, it was 
infrequent for DNA methylation to spread from an IAP to neighbouring gene promoters, 
except where genes lie within 500bp of an IAP (Rebollo et al., 2011). Our results now 
implicate a KAP1/ESET complex in this mechanism. Since DNA methylation rarely 
spreads from ERVs as far as nearby promoters in the genome, in future work it will be 
interesting to investigate the possible presence of barrier elements protecting cellular 
genes from the spread of repressive marks including DNA methylation, nucleated at ERV 
sequences. 
 
Here, we observed significant DNA methylation of a PBS Pro-, retroviral promoter-
containing lentiviral vector in MEFs, which express similar levels of ZFP809 to ES cells, 
as well as in 293T cells engineered to express high levels of this KRAB-ZFP. In contrast, 
a KAP1-restricted IAP sequence induced neither repression nor de novo DNA 
methylation of the MND promoter in MEFs, suggesting that the cognate KRAB-ZFP is 
not expressed in these targets. The matching KRAB-ZFP(s) could be any of those 
enriched in ES cells except ZFP568, which has already been shown not to be responsible 
for repressing IAPs in vivo (Shibata et al., 2011). That ZFP809 induced only low 
methylation in MEFs and 293T cells, compared to ES cells, explains why the repression 
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is reversible, as previously noted when KRAB is artificially tethered to a promoter in cell 
lines (Barde et al., 2009; Groner et al., 2010; Quenneville et al., 2012; Wiznerowicz and 
Trono, 2003). 
 
Surprisingly, we found very little decrease in DNA methylation levels at resident ERVs 
in KAP1 knockout embryos despite the hereby-demonstrated role of KAP1 in shaping 
DNA methylation patterns at ERV sequences in embryogenesis. It could be that loss of 
DNA methylation that follows loss of repressive histone marks can not be measured 
accurately due to the earlier lethality of knockout embryos (at or before E5.5) (Cammas 
et al., 2000) or that the majority of DNA methylation at genomic ERVs is KAP1-
independent at this stage. Along these lines, since IAPs are relatively resistant to genome-
wide DNA demethylation in pre-implantation embryos (Lane et al., 2003), methylation 
may be maintained without requiring de novo methyltransferase activity. Importantly, this 
and previous studies (Matsui et al., 2010; Rowe et al., 2010) indicate that histone 
modifications, rather than DNA methylation, are primarily responsible for silencing 
ERVs in ES cells, as IAPs get immediately and markedly upregulated upon KAP1 or 
ESET removal in ES cells, in the absence of any spectacular change in their DNA 
methylation status. It is noteworthy that ERVs exhibit of range of DNA methylation rates 
in ES cells, suggesting that some, including many IAPs, may escape demethylation, while 
others may get demethylated but rapidly re-methylated following their KRAB/KAP1 
recognition. Moreover, the impact of DNA methylation per se on transcription, at least 
during this period, needs to be further investigated, as blocking histone-based repression 
of IAPs suffices to induce their upregulation. It may be that subtle alterations at specific 
positions, critical to block transcription, have so far escaped analyses, or that DNA 
methylation does not have the same consequences in ES and somatic cells, for instance if 
some factors important for repressing transcription at DNA methylated loci are expressed 
in differentiated but not in undifferentiated cells. 
 
Our in vivo experiments with vectors reveal that ERV methylation patterns are faithfully 
copied late into development leading to extremely high DNA methylation levels 
(upwards of 80%) that mimic natural levels at IAP LTRs resident in the genome. The 
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self-perpetuating nature of DNA methylation alleviates the need for the continuous 
expression of cognate ERV-binding KRAB-ZFP repressors. It also explains why the 
maintenance of DNA methylation at ERVs throughout development is critical to suppress 
their transcription, notably for IAPs (Walsh et al., 1998). In sum, the present work 
implies that ERV sequence recognition by KRAB-ZFPs/KAP1 and the lysine 
methyltransferase ESET is necessary to target ERV-containing loci for rapid de novo 
DNA methylation in early development, leading to stable site-specific DNA methylation 
signatures across the genome. 
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FIGURE LEGENDS 
 
Fig. 1: ERV sequences can induce rapid de novo DNA methylation in ES cells 
A) Technique to measure repression and DNA methylation. Left: In a lentiviral vector, 
ERV sequences are cloned either immediately upstream (shown here) or downstream (as 
stated per experiment) of an internal promoter and repression measured by GFP. Bisulfite 
quantitative pyrosequencing of the promoter (middle) reveals the ratio of thymine (T) vs. 
cytosine (C) at each CpG position (shaded in grey) to determine the % DNA methylation. 
Right: Validation with primers for global IAP LTRs and the Oct4 promoter, p=0.0022. 
Points show individual CpG positions. B) ERV-directed repression of a GFP reporter in 
ES cells. Left: Flow cytometry 4 days post transduction. All vectors had an internal 
“MND” promoter (Rowe et al., 2010), which was empty or contained an ERV sequence 
(Pro, B2, IAP1, IAP2, IAP3 or IAP4) either upstream (when written before MND) or 
downstream (when written after MND) of the promoter. Both E14 ES and ES3 ES cell 
lines showed significant ERV repression (p=0.0260 and p= 0.0311 respectively, unpaired 
one-tailed t tests) compared to control vectors (shown in green). Repression is normalized 
to the MND B2 control vector and to expression in 3T3 control cells. Right: GFP mRNA 
quantification (normalized to titin) for one representative cell line 6 days post 
transduction; repressed vectors showed significantly less mRNA than controls (shown in 
green), p=0.0042 (unpaired one-tailed t test). C) Day 4 analysis of de novo methylation at 
the MND promoter. N=10 (CpG positions – see map). Here the methylation profile is 
also shown for the MND Pro vector in 3T3 control cells. Significant differences in ES 
cells:  The MND Pro vs. MND B2 vector (p=0.0006); IAP2 MND (p=0.001) or IAP3 
MND or MND IAP2 or MND IAP4 (p=<0.0001 for all) all vs. the IAP1 MND control 
vector. 
 
Fig. 2: ERV DNA methylation patterns are conditioned by KRAB-ZFP expression 
profiles 
A) Comparison of expression levels of selected KRAB-ZFPs in ES cells and MEFs based 
on mRNA-sequencing data. Rpkm: The number of sequencing reads normalized by gene 
length and to the total read number. B) The Pro sequence is repressed in MEFs where 
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ZFP809 expression is retained. Top: The MND Pro vector is repressed in MEFs 
compared to the empty (MND) or IAP2 MND vector, whereas all vectors are highly 
expressed in 3T3 cells (bottom). Mock: nontransduced. C) The Pro sequence directs de 
novo promoter methylation in MEFs. DNA methylation was measured at days 4 and 12 
post transduction with the stated vectors. Promoter methylation of the MND Pro vector 
was also measured in 3T3 cells at day 12 as a control. P values: p=0.0052 (day 4) and 
p=0.0001 (day 12). D) 293t cells were complemented with ZFP809 (or LacZ as a control) 
and expression compared to endogenous levels in the stated cells by qRT-PCR. Bars 
show means and s.e.m. of triplicate transfections (293t cells) or 2 independent cell lines 
(MEFs) or individual cell lines (EC and ES cells).  E) and F) ZFP809 is responsible for 
Pro-sequence directed repression and DNA methylation. 293t cells were transduced with 
the stated vectors (or nontransduced: Mock) and then transfected with either ZFP809 or 
LacZ. GFP repression (E) and promoter methylation (F) were measured 5 days post 
transfection. P=0.0042. 
 
Fig. 3: KAP1 and ESET are required for de novo DNA methylation of ERVs 
A) Kap1-inducible knockout (KO) ES cells were genotyped 3 days post excision by PCR. 
Triplicate samples of independently excised cells are shown. 171- and 390-bp products 
represent loxP-flanked or excised Kap1, respectively. B) Fold repression 48 hours post 
vector transduction (and 3 days post Kap1 excision). Vectors were titered on 3T3 cells 
first so that equal infectious units between vectors could be used for transduction of ES 
cells and 3T3 cells in parallel. Results were then normalized to the MND B2 control 
vector and to 3T3 cell expression. One representative experiment of two is shown. C) 
The same samples from B) were used to assess de novo methylation of the MND 
promoter over 10 CpG positions (see Fig. 1C for a CpG map). One representative 
experiment of two is shown. P values: MND Pro vs. MND B2, p=0.0001; IAP2 MND vs. 
MND B2, p=<0.0001. D) Eset-inducible knockout (KO) ES cells were assessed for a 
reduction of ESET (or DNMT mRNAs as a control) 3 days post excision by qRT-PCR. 
E) Fold repression 48 hours post vector transduction (and 3 days post Eset excision) 
normalized as in B). One representative experiment of two is shown. F) The same 
samples from E) were used to assess de novo methylation of the MND promoter over 10 
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CpG positions. One representative experiment of two is shown. P values: MND Pro vs. 
MND B2, p=0.0085; IAP2 MND vs. MND B2, p=0.0014. 
 
Fig. 4: ERV-guided KAP1-induced DNA methylation is recapitulated in 
embryogenesis 
A) The MND and IAP2 MND vectors were used for lentiviral transgenesis with scoring 
of embryos for vector integration and GFP expression at E13. For the MND group, 6 
embryos were integrated with copy numbers stated (top) and for the IAP2 MND group, 
10 embryos were integrated, none of which were green with 7 shown (bottom). B) MEFs 
were cultured from sample embryos (stated on the right) or a non-integrated embryo as a 
control and GFP measured by flow cytometry. C) Embryos from A) (N=6 for MND and 
N=7 for IAP2 MND) were assessed for methylation of the MND promoter (means are 
shown per embryo over 10 CpGs). P=0.0057 (unpaired two-tailed t test). 
 
Fig. 5: ERV sequences can induce repression and DNA methylation of a cellular 
promoter 
A) Side-by-side comparison in ES cells of repression and DNA methylation of the MND 
vs. PGK promoter using vectors with either the B2 or Pro sequence cloned upstream 
(written before) or downstream (written after) of each promoter at day 3. Vectors were 
normalized on 3T3 cells, which were analysed as a control for DNA methylation (the 
PGK Pro and MND Pro samples). One representative experiment of two is shown. P 
values are <0.0001 (Pro MND vs. B2 MND and MND Pro vs. MND B2). B) Fold 
repression (left, normalized to the PGK B2 vector and to expression in 3T3 cells) and 
DNA methylation (right) of the PGK promoter within the stated vectors at 6 and 12 days 
post transduction. 3T3 cells (day6) were analysed as a negative control for DNA 
methylation. P values over 10 CpGs for day6: PGK B2 vs. PGK Pro, p=<0.0001 or vs. 
IAP4 PGK, p=0.0227. For day12: PGK B2 vs. PGK Pro, p=<0.0001 or vs. IAP4 PGK, 
p=<0.0001. C) The Pro sequence directs methylation of the PGK promoter in vivo. 0/5 
integrated embryos were green for the PGK Pro vector vs. 4/9 green for the empty (PGK) 
vector. One embryo is shown for each (top) where the copy numbers were 2.4 (PGK Pro) 
and 2.8 (PGK). Bottom: DNA methylation results for the top embryos and others 
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(numbered). PGK Pro 1. and 2. are significantly more methylated than PGK 1., p=0.0003 
and p=0.0004 respectively. One representative experiment of three is shown here. 
 
Fig. 6: KAP1 shapes DNA methylation of endogenous retroviruses in ES cells and 
embryos 
A) KAP1 knockout in ES cells leads to an accumulation of IAP GAG p73 expression. ES 
cells with loxP-flanked Kap1 untreated (1.) or treated with 4-OHT (2.) or transduced with 
4-OHT-inducible Cre, without (3.) or with 4-OHT (4.). Cells were harvested 4 days post 
4-OHT treatment. B) KAP1 WT and KO ES cells were analysed for DNA methylation of 
global IAP LTRs (bottom). Methylation of the Oct4 promoter (top), G9a KO ES cells and 
KAP1 KO MEFs were used as controls. P values for the IAP LTR: KO MEFs were not 
different to WT MEFs (p=0.2186); KAP1 KO ES cells were significantly different to WT 
(p=0.0008) and G9a KO ES were significantly different to WT (p=0.0002). C) Kap1 
heterozygous mice (C57BL/6) were crossed and embryos dissected at E5.5 to measure 
DNA methylation of endogenous IAPs using primers either in the 5’UTR (top) or LTR 
(bottom). Here two knockouts and one WT embryo were analysed. Top: p=0.0059 and 
0.0006 respectively. Bottom: p=0.1613 (not significant) and 0.0493 respectively (paired 
one-tailed t tests). D) Summary model: KRAB-ZFPs, KAP1 and ESET are necessary for 
de novo methylation of ERVs, occurring within 48 hours. This process is sequence-
specific and takes place in ES cells and embryogenesis. 
 
Fig. 7: DNA methylation of introduced ERV sequences and resident ERVs becomes 
critical late in development 
A) Transgenic MEFs from Fig. 5C and additionally, a MEF cell line not containing any 
vector (non-transgenic) were treated with 5-Aza (48 hours) or TSA (24 hours) or left 
untreated and GFP measured the next day. While TSA could increase the % GFP of 
MEFs transgenic for the empty vector (PGK 1.), GFP was only resurrected in Pro vector-
transgenic MEFs upon 5-Aza addition. B) In the same experiment as shown in A), 
endogenous IAP transcripts were also measured in the stated MEF lines by qRT-PCR. 
Fold upregulation is shown normalized to untreated controls for each cell line. 
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• Eight Supplementary Figures 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• Supplementary 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primers 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Figure  S1,  related  to  Figure  1:  ERV  sequences  can  induce  rapid  de  novo  DNA 
methylation in ES cells 
A)  Genomic  DNA  samples  from  Figure  1B‐C  (time‐point  day  4)  were  used  to measure  relative  vector  copies  by Q‐PCR,  to  verify  that  repressed  vectors  did  not represent non‐integrated samples. B) De novo methylation and repression are rapid and progressive thereafter. Left: ERV‐containing (Pro or IAP2) vectors or a control vector (B2) were measured for their levels of promoter methylation at 3, 4 or 7 days post  transduction. Right:  In parallel,  fold repression was recorded at days 3 and 7 post  transduction. Left p values: Day3: MND B2 vs. MND Pro  (0.0016) or vs.  IAP2 MND  (0.0009);  Day4:  MND  B2  vs.  MND  Pro  (0.0007)  or  vs.  IAP2  MND  (0.0011); Day7: MND B2 vs. MND Pro (0.0016) or vs. IAP2 MND (0.0001). 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Figure S2, related to Figure 2: ERV DNA methylation patterns are conditioned by 
KRAB­ZFP expression profiles Reversibility  of  MND  Pro  silencing  in  MEFs  and  293t  cells  where  levels  of  DNA methylation  induced  are  very  low.  A)  MEFs  shown  in  Figure  2B  transduced with either the MND or MND Pro vector were cultured for 2 weeks and then transduced with shRNA vectors that were Puromycin selected (either against KAP1 or with an empty  vector  control)  as  stated.  One  week  later,  GFP  was  analysed  by  flow cytometry. B)  293t  cells  from Figure 2E  transduced with  either  the MND or MND Pro  vectors  and  transfected with  ZFP809  and  then washed  and maintained  for  5 days longer to allow loss of ZFP809 expression and reversibility of Pro repression. 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Figure  S3,  related  to  Figure  3:  KAP1 and ESET are required for de novo DNA 
methylation of ERVs KAP1 knockout is lethal in ES cells around 4‐5 days post Kap1‐ excision. Cells were therefore assessed for DNA methylation at 3 days post Kap1­excision (see Figure 3). Here, Kap1 LoxP‐flanked cells were transduced with a 4‐OHT inducible Cre vector in the absence (KAP1 Cre ES) or presence (KAP1 KO ES) of 4‐OHT. Two cell  lines are shown (ES3 and ES6). Four days post Kap1‐ excision, cells were harvested, stained and  assessed  for  cell  death  by  flow  cytometry.  Note  that  cell  death  is underestimated since some cells die and detach before harvesting. 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Figure  S4,  related  to  Figure  5: ERV  sequences  can  induce  repression  and DNA 
methylation of a cellular promoter 
A)  Side‐by‐side  comparison  of  repression  of  the  MND  promoter  vs.  the  cellular promoter PGK at day3 and day6 post vector transduction of F9 EC cells and ES cells. Results  were  normalized  to  expression  in  3T3  cells  and  fold  repression  of  PGK vectors  was  normalized  to  the  PGK  B2  control  vector,  while  MND  vectors  were normalized  to  the MND B2  control  vector.  Bars  show means  and  s.d.  of  triplicate infections. P values (unpaired two‐tailed t tests) for the PGK Pro vector vs. the PGK control:  EC  day3,  p=0.0492;  ES  day3,  p=0.0406;  EC  day6,  p=0.0016;  ES  day6, p=0.0012. For the MND Pro vector vs. the MND control: EC day3, p=0.0119; ES day3, p=0.0009; EC day6, p=0.0125; ES day6, p=0.0026. B) ERV sequences can direct de 
novo  methylation  of  the  PGK  promoter  in  vivo.  Lentiviral  transgenesis  was performed with either the IAP4 PGK vector or a control vector, IAP1 (see Figure 1) PGK  that  escapes  repression.  5  embryos  per  group  were  assessed  for  DNA methylation of the PGK promoter. P=0.0270. 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IAP 5’LTR, chr11: 98613616 - 98620038
Figure  S5,  related  to  Figure  6: KAP1  shapes  DNA  methylation  of  endogenous 
retroviruses in ES cells and embryos Bisulphite  sequencing  with  TOPO  cloning  showing  the  difference  in  DNA methylation status between molecules at one IAP locus. KAP1 knockout (ko) ES cell samples  shown  in  red  and  wildtype  (wt)  ones  in  black.  Sequences  are  ordered depending  on  methylation  density.  Unfilled  and  filled  lollipops  represent unmethylated and methylated CpGs respectively. 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Figure S6, related to Figure 7: DNA methylation of introduced ERV sequences and 
resident ERVs becomes critical late in development MEFs from Figure 7AB (line PGK Pro 1.) were used for DNA methylation analysis by bisulphite pyrosequencing at endogenous IAPs in parallel to the expression analysis shown in Figure 7B. DNA methylation was reduced in the 5‐Aza treated group. 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Figure S7
Figure  S7,  related  to  Figure  6: KAP1  shapes  DNA  methylation  of  endogenous 
retroviruses in ES cells and embryos 
Kap1  heterozygous mice were  crossed  and  embryos  dissected  at  E5.5  to measure DNA methylation of endogenous  IAPs. Here  the results of  the genotyping  that was done by PCR with a mix of three primers (see Figure 3) are shown. 171‐ and 390‐bp products represent loxP­flanked or excised Kap1, respectively. Embryos selected for analysis  (two knockouts  and one WT embryo)  are  labelled. The  image  shows  two parts of the same gel but all at the same exposure and analysis settings. 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Figure  S8,  related  to  Figure  7: DNA methylation  of  introduced  ERV  sequences 
and resident ERVs becomes critical late in development 
A) Accumulation of IAP GAG p73 in DNA methyltransferase triple knockout ES cells 
(DNMT TKO). 3T3 cells were a positive control since they overexpress IAP GAG. 
Global OCT4 protein levels were comparable between WT and TKO ES cells. B) qRT-
PCR showing upregulation of IAP and MERVL transcripts in DNMT TKO cells. 
Samples were normalized to Gapdh and G9a levels were also similar between samples 
while DNMT1 and 3B were verified to be absent in DNMT TKO cells. C) WT and 
DNMT TKO ES cells were stained with an anti-SSEA1 antibody or left unstained and 
histogram results overlaid to verify that cells were largely undifferentiated. D) In another 
experiment, ES cells were cultured for six days in the presence or absence of LIF and 
then stained as in C) above to verify that cells downregulate SSEA1 upon differentiation 
to validate its use as a marker of undifferentiation in C). 
Supplementary Table I: Primer sequences  
  
qRT-PCR primers  
GFP_F CTGCTGCCCGACAACCAC 
GFP_R ACCATGTGATCGCGCTTCTC 
GFP_probe CCAGTCCGCCCTGAGCAAAGACC 
Titin_F TTCAGTCATGCTGCTAGCGC 
Titin_R AAAACGAGCAGTGACGTGAGC 
Titin_probe TGCACGGAAGCGTCTCGTCTCAGTC 
Actin_F TAGGCACCAGGGTGTGATGG 
Actin_R  CATGGCTGGGGTGTTGAAGG 
KAP1_F CGGAAATGTGAGCGTGTTCTC 
KAP1_R CGGTAGCCAGCTGATGCAA 
Gapdh_F TCCATGACAACTTTGGCATTG 
Gapdh_R CAGTCTTCTGGGTGGCAGTGA 
G9A_F AGACAGCCCGTGGGTGAA 
G9A_R CCCTCGGAGGCTCTCGTT 
DNMT1_F CCAGGCATTTCGGCTGAA 
DNMT1_R CGTTGCAGTCCTCTGTGAACA 
DNMT3b_F AACTCCATCAGACAGGGCAAA 
DNMT3b_R CGTCCTTGCCATTCATGACTAC 
ESET_F TGGCAACAGCGGTTCAGA 
ESET_R CAGAAGTTATCATCAGAGCTGTCATCA 
Zfp809_F AATTTGGAGCGTGGATTTGG 
Zfp809_R GGGAGGCTCCTGCTTGAAG 
EeF1a1_F AGCAAAAATGACCCACCAATG 
EeF1a1_R GGCCTGGATGGTTCAGGATA 
EeF1a1_probe CACCTGAGCAGTGAAGCCAGCTGCTT 
  
qPCR copy number primers  
HIV_GAG_F GGAGCTAGAACGATTCGCAGTTA 
HIV_GAG_R GGTGTAGCTGTCCCAGTATTTGTC 
HIV_GAG_probe ACAGCCTTCTGATGTTTCTAACAGGCCAGG 
GFP_F CTGCTGCCCGACAACCAC 
GFP_R ACCATGTGATCGCGCTTCTC 
GFP_probe CCAGTCCGCCCTGAGCAAAGACC 
Titin_F TTCAGTCATGCTGCTAGCGC 
Titin_R AAAACGAGCAGTGACGTGAGC 
Titin_probe TGCACGGAAGCGTCTCGTCTCAGTC 
  
Bisulphite pyrosequencing 
primers  
Oct4_Promoter_F AGGGGTGAGAGGATTTTGAA 
Oct4_Promoter_biotin_R  CCACCCTCTAACCTTAACCT 
Oct4_Promoter_seq GGTTGAAAATGAAGGTTT 
IAP LTR_biotin_F GGTTTTGGAATGAGGGATTTT 
IAP LTR_R CTCTACTCCATATACTCTACCTTC 
IAP LTR_seq ATACTCTACCTTCCCC 
IAP 5'UTR_F GGGTTGTAGTTAATTAGGGAGTGATA 
IAP 5'UTR_biotin_R ACAATTAAATCCTTCTTAACAATCTACTT 
IAP 5'UTR_seq ATTTTGGTTTGTTGTGT 
MND_F TTAGATGTTTTTAGGGTGTTTTAAGGA 
MND_biotin_R TCACTCAAAAAAAACCCTCCCAAAAAA 
MND_seq TGATTTTGTGTTTTATTTGAATTAA 
hPGK_F GGTTGGGGTTGAGTTTTTTTTAAGGTA 
hPGK_biotin_R CTAAACAACCCCTATTAACCACAACCCAT 
hPGK_seq GTTTTTAAGTAGGGAAGGTTTT 
   
